| Name | Title | Contact Details |
|---|---|---|
Dustin Holloway |
AI Governance Professional | AI Scientist and experienced Executive | Vice President and Global Head of Responsible Innovation | PhD, MPH, AIGP | Profile |
Jonathan Amar |
Assistant General Counsel | Profile |
Ellen McCabe |
Assistant General Counsel | Profile |
Jessica Weber |
Senior Corporate Counsel, Specialty Care | Profile |
Stephanie Donahue |
Head of Global Patent Litigation | Profile |
Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
Fluidx Medical Technologys novel GPX Embolic Device is a durable embolic that is easy to use, controllable, and effective for vessel occlusion.
Digestive Care Inc is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BestCo is a leading developer and manufacturer of innovative pharmaceutical dosage forms for the OTC (Over-the-Counter) Drug, Vitamin and Supplement marketplace.
Vallon is a biopharmaceutical company focused on the development and commercialization of novel abuse-deterrent medications for CNS disorders. $VLON